1. Merck to buy Pandion for $1.9B for its immune modulators — Biden looking beyond Woodcock or Sharfstein for FDA commmisioner — Former AveXis execs launch gene therapy startup See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

"Cook the Books" Beyer

Discussion in 'Exact Sciences' started by Anonymous, Apr 10, 2015 at 12:20 PM.

  1. #1 Anonymous, Apr 10, 2015 at 12:20 PM
    Anonymous

    Anonymous Guest

    Why do we have issues at the end of every quarter regarding Tableau, bonus and quota? Is the company intentionally deceiving reps? Been like that since the inception.
     
    Quote
  2. #2 Anonymous, Apr 10, 2015 at 1:01 PM
    Anonymous

    Anonymous Guest

    It's about eradicating cancer. Don't be selfish and worry about bonus.
     
    Quote
  3. #3 Anonymous, Apr 10, 2015 at 1:38 PM
    Anonymous

    Anonymous Guest

    Just wait until you see how high your quota is this quarter. Don't reach it, and you will be eradicated soon.
     
    Quote
  4. #4 Anonymous, Apr 10, 2015 at 5:55 PM
    Anonymous

    Anonymous Guest


    For Sure LOL . People just can't wait to use that BUCKET. Sell those BUCKETS signed KING CONROY
     
    Quote
  5. #5 Anonymous, Apr 12, 2015 at 10:07 PM
    Anonymous

    Anonymous Guest

    Beyer is changing numbers? Cant sat, but sure wish he could get a comp that motivates and is solid. Does he even know how to create a good plan?
     
    Quote
  6. #6 Anonymous, Apr 12, 2015 at 11:18 PM
    Anonymous

    Anonymous Guest

    What is wrong with the plan?
     
    Quote
Reply to Thread